HR 4278 · 117th Congress
To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
This bill hasn't been enriched yet — fetch cosponsors, actions, subjects, titles, and summaries from Congress.gov.
Latest action
2021-07-01 — Referred to the Subcommittee on Health.
Sponsor
Gregory MurphyCosponsors
Cosponsors not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-4278
to populate.
Action history
Action history not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-4278
to populate.
Subjects
Subjects not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-4278
to populate.
Titles
Titles not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-4278
to populate.
Summaries
Summaries not yet fetched. Run
concord scrape bills enrich --bill-ids 117-hr-4278
to populate.
Vote history
No votes recorded for this bill yet.
Coming in later phases
Committee path (Phase 4)
Committee referrals and reports will appear here.
Search within this bill (Phase 5)
Bill text will become searchable here.